1Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi'S anem ia by means of umbilical cord blood from an HLA-identical sibling[J]. N Engl J Med, 1989, 321: 1174-1178.
5Food and Drug Administration, Center for biologics evaluation and research[S] . Guidance for human somatic cell therapy and gene therapy, 1998.23-26.
6国家食品药品监督管理局.人体细胞治疗研究和制剂质量控制技术指导原则[S].2003-03-20.
二级参考文献17
1[1]GLUCKMAN E, BROXMEYER H E, AUERBACH,et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling [J]. N Engl J Med,1989, 321 (117): 1174-1178.
2[2]KURTZBERG J, LAUGHLIN M, GRAHAM M L,et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients[J]. N Engl JMed, 1996, 335 (3): 157-166.
3[3]BRIDDELL R, KERN B P, ZILM K L, et al. Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells [J]. J Hematother, 1997, 6 (2): 145-150.
4[4]SHPALL E J, QUINONES R, JONES R, et al.Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo [J].Blood, 1999, 94 (sup 1): 712-719.
5[5]MCNIECE I, JONES R, BEARMAN S, et al. Rapid engraftment of neutrophils using ex vivo expanded PBPC correlates with total nucleated cells and not CD34+ cells[J]. Blood, 1999, 94 (sup 1): 554-560.
6[6]MCNIECE I K, BERTONCELLO I, KRIEGLER A B, et al. Colony-forming cells with high proliferative potential (HPP-CFC)[A]. Concise Reviews in Clinical and Experimental Hematology [C]. Miami: Alpha MedPress, 1992. 267-277.
7[7]MCNIECE I, KUBEGOV D, KERZIC P, et al. Increased expansion and differentiation of cord blood products using a two-step expansion culture[J]. Exp Hematology, 2000, 28 (10): 1181-1186.
8Gluckman E,Broxmeyer HE,Auerbach AD,et al.Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from a HLA-identical simbling.N Engl J Med,1989,321:1174-1178.
9Wagner JE,Barker JN,deFor TE,et al.Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant disease:influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.Blood,2002,100:1611-1618.
10PETERS C, LADENSTEIN R, MINKOV M, et al. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres:a report from the EBMT Working Party on Paediatric Diseases [ J ]. Bone Marrow Transplant,1998,22(5):431-437
